Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

5.54
Delayed Data
As of 3:59pm ET
 -0.01 / -0.18%
Today’s Change
3.50
Today|||52-Week Range
43.37
-38.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$256.5M

Company Description

Chimerix, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel, oral antiviral therapeutics designed to address unmet medical need. Chimerix was founded by George R. Painter and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

Contact Information

Chimerix, Inc.
2505 Meridian Parkway
Durham North Carolina 27713
P:(919) 806-1074
Investor Relations:
(919) 287-4125

Employees

Shareholders

Other institutional34.95%
Mutual fund holders32.74%
Individual stakeholders19.39%

Top Executives

M. Michelle BerreyPresident, Chief Executive Officer & Director
Timothy W. TrostChief Financial Officer, Secretary & Senior VP
Hervé Momméja-MarinVice President-Clinical Research
William Garrett NicholsChief Medical Officer
Linda M. RichardsonChief Commercial Officer